News & Views

Ali Pashazadeh, Treehill Partners CEO was part of a series of interviewees for Mari Serebrov's viewpoints poll right after the U.S. elections 2024...
Introducing a mechanism for patenting a new potential use for a drug technology for a period of time after publishing clinical trial data...
Ali Pashazadeh, Treehill’s CEO, contributes to an article in Mergermarket summarising current trends in the European immunology, inflammatory and autoimmune marketplaces...
It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets...